Healthcare Equipment and Supplies
Company Overview of B. Braun Melsungen AG
B. Braun Melsungen AG, together with its subsidiaries, manufactures, markets, and sells various healthcare products and services for intensive care units, anesthesia and emergency care, extracorporeal blood treatment, and surgical core procedures worldwide. The company’s Hospital Care division supplies IV sets and accessories, infusion and injection solutions, intravenous catheters, and clinical nutrition products, as well as pumps and associated systems; disposable medical and wound drainage products; pharmaceuticals and products for drug admixture and regional anesthesia; and automated infusion systems. Its Aesculap division develops and distributes products and services for surgical, orth...
Founded in 1839
Key Executives for B. Braun Melsungen AG
Chief Financial Officer and Member of Management Board
Member of Management Board and Chief Executive Officer of B Braun America
Chairman of Management Board and Director of Human Resources, Legal Affairs & Labor Relations
Senior Vice President of Corporate Communications & Knowledge Management
Production Director and Member of Supervisory Board
Compensation as of Fiscal Year 2015.
B. Braun Melsungen AG Key Developments
B. Braun Melsungen AG Announces Earnings Results for the Fiscal Year of 2014; Provides Sales Guidance for the Fiscal 2015
Mar 27 15
B. Braun Melsungen AG announced earnings results for the fiscal year of 2014. The company booked record revenue in 2014 despite the negative currency effects. Revenue gained 5% on the year to EUR 5.43 billion (USD 5.87 billion) compared to EUR 5,169.5 million a year ago. Net profit grew only 0.3% to EUR 316.3 million due to negative currency effects of about EUR 85 million. EBITDA was EUR 798.4 million compared to EUR 784.9 million a year ago.
For fiscal 2015, the company expects further sales growth at constant exchange rates of between 4% and 6%.
B Braun Plans To Acquire Additional Stake In Rhon-Klinikum
Sep 3 13
B. Braun Melsungen AG plans to acquire an additional stake in Rhön-Klinikum Aktiengesellschaft (DB:RHK) to above 25% in order to block possible acquisitions. B. Braun still needs the approval of German cartel office for the acquisition.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries